- Home
- MOMO vs AUPH Comparison
MOMO vs AUPH Comparison
Compare MOMO & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOMO
- AUPH
- Stock Information
- Founded
- MOMO 2011
- AUPH 1993
- Country
- MOMO China
- AUPH Canada
- Employees
- MOMO N/A
- AUPH N/A
- Industry
- MOMO Computer Software: Prepackaged Software
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- MOMO Technology
- AUPH Health Care
- Exchange
- MOMO Nasdaq
- AUPH Nasdaq
- Market Cap
- MOMO 1.1B
- AUPH 1.1B
- IPO Year
- MOMO 2014
- AUPH 1999
- Fundamental
- Price
- MOMO $6.29
- AUPH $8.14
- Analyst Decision
- MOMO Buy
- AUPH Strong Buy
- Analyst Count
- MOMO 3
- AUPH 2
- Target Price
- MOMO $8.67
- AUPH $11.50
- AVG Volume (30 Days)
- MOMO 1.6M
- AUPH 1.5M
- Earning Date
- MOMO 03-12-2025
- AUPH 05-01-2025
- Dividend Yield
- MOMO 4.40%
- AUPH N/A
- EPS Growth
- MOMO N/A
- AUPH N/A
- EPS
- MOMO 0.76
- AUPH 0.04
- Revenue
- MOMO $1,447,160,744.00
- AUPH $235,133,000.00
- Revenue This Year
- MOMO N/A
- AUPH $11.86
- Revenue Next Year
- MOMO $3.52
- AUPH $24.96
- P/E Ratio
- MOMO $8.30
- AUPH $201.38
- Revenue Growth
- MOMO N/A
- AUPH 33.97
- 52 Week Low
- MOMO $4.79
- AUPH $4.71
- 52 Week High
- MOMO $8.38
- AUPH $10.67
- Technical
- Relative Strength Index (RSI)
- MOMO 35.19
- AUPH 45.11
- Support Level
- MOMO $6.15
- AUPH $7.93
- Resistance Level
- MOMO $6.66
- AUPH $8.73
- Average True Range (ATR)
- MOMO 0.21
- AUPH 0.22
- MACD
- MOMO -0.05
- AUPH -0.04
- Stochastic Oscillator
- MOMO 16.24
- AUPH 16.25
Stock Price Comparison Chart: MOMO vs AUPH
About MOMO Hello Group Inc.
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines out of which Momo's service lines segment derives the majority of revenue.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.